The largest database of trusted experimental protocols

Irisin elisa kit ek 067 52

Manufactured by Phoenix Pharmaceuticals
Sourced in United States

The Irisin ELISA Kit EK-067-52 is a quantitative sandwich enzyme-linked immunosorbent assay (ELISA) designed for the detection and quantification of irisin levels in biological samples. The kit utilizes a specific antibody coated on a 96-well plate to capture irisin, which is then detected using a detection antibody conjugated with an enzyme. The enzymatic reaction produces a color change proportional to the amount of irisin present in the sample.

Automatically generated - may contain errors

4 protocols using irisin elisa kit ek 067 52

1

Quantification of Serum Irisin Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood collected from mice injected with DB or irisin twice a week for 4 weeks were incubated at room temperature (RT) for 30 min. Blood samples were then centrifuged at 1500×g for 15 min at 4 °C and serum was isolated. Irisin levels in the serum were quantified using a commercial ELISA kit following the manufacturer’s protocol (Irisin ELISA kit EK-067−52, Phoenix Pharmaceuticals, Inc., USA) using spectrophotometry at a wavelength of 450 nm. The detection range of the kit is 0.1–1000ng/ml.
+ Open protocol
+ Expand
2

Quantifying Irisin in Human Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples from overall participants were obtained under basal conditions after a 12-h overnight fast. EDTA-plasma and serum of specimen were separated from whole blood and immediately frozen at −80° C until assay.
The quantitative measurement of irisin in human plasma samples was performed using a commercial enzyme-linked immunosorbent assay (ELISA) kit directed against amino acids 31–143 of the FNDC5 protein (Irisin ELISA Kit EK-067-52; Phoenix Pharmaceuticals, INC, CA) according to the manufacturer’s instructions. Absorbance from each sample was measured in duplicate using a spectrophotometric microplate reader at wavelength of 450 nm (Versamax Microplate Reader; Associates of Cape Cod Incorporated, East Falmouth, MA).
+ Open protocol
+ Expand
3

Quantitative Irisin Measurement in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
The quantitative measurement of irisin in human plasma samples was performed using a commercial enzyme-linked immunosorbent assay (ELISA) kit directed against amino acids 31–143 of the FNDC5 protein (Irisin ELISA Kit EK-067-52; Phoenix Pharmaceuticals Inc., CA) according to the manufacturer's instructions. The absorbance from each sample was measured in duplicate using a spectrophotometric microplate reader at wavelength of 450 nm (Versamax Microplate Reader; Associates of Cape Cod Incorporated, East Falmouth, MA).
Insulin was analysed by an immunoradiometric assay (BioSource International, Camarillo, CA, USA) in a Beckman Coulter (Fullerton, CA, USA), showing 0.3% cross-reaction with proinsulin. The intra- and interassay CV were 1.9% and 6.3%, respectively. Glucose was measured using a Dimension Autoanalyzer (Dade Behrng, Deerfield, IL, USA). The homeostatic model assessment index (HOMA-IR) was calculated following the formula (fasting plasma glucose (mg/mL) × fasting plasma insulin (mU/L)/405), as described elsewhere [27 (link)].
+ Open protocol
+ Expand
4

Serum Irisin and Metabolic Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Participants underwent blood sampling for the assessment of blood chemistry and hormonal parameters. The quantitative measurement of irisin in human serum samples was performed using a commercial enzyme linked immunosorbent assay (ELISA) kit (Irisin ELISA Kit EK-067-52; Phoenix Pharmaceuticals Inc., CA) according to the manufacturer’s instructions. Basal insulin was analyzed by an immunoradiometric assay (BioSource International, Camarillo, CA, USA) in a Beckman Coulter (Fullerton, CA, USA). Enzymatic colorimetric assay was used to measure fasting plasma glucose (FPG) (Hexokinase activity assay, Abcam), total cholesterol (Cholesterol Gen.2, Roche), high-density lipoproteins (HDL) cholesterol (LDL-Cholesterol plus 2nd generation, Roche), triglycerides (Triglycerides/Glycerol Blanked, Roche) concentrations using a Dimension Autoanalyzer (Cobas501, Roche, Switzerland). The homeostatic model assessment index was calculated following the formulas: HOMA-IR = fasting serum insulin (FINS, mU/L) × fasting plasma glucose (FPG, mmol/L)/22.5; HOMA-IS = 1/(FPG (mmol/L) × FINS (mIU/L)). Low-density lipoprotein (LDL) cholesterol serum concentration was calculated with Friedewald’s formula.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!